Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,140.40
(
0.52%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.64
(
2.38%
)
Bitcoin
74,755.92
(
-0.12%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 68027

Thursday, 02/12/2009 5:48:32 PM

Thursday, February 12, 2009 5:48:32 PM

Post# of 257253
Sanofi Reports 4Q08 Annualized Lovenox Sales of $3.8B

[The sales figures are in Euros, Sanofi’s reporting currency, and the growth rates are in constant local currencies, which is a way to track the growth in volume and price irrespective of currency swings. (Sanofi does not report quarter-over-quarter growth in local currencies, and hence meaningful quarter-over-quarter numbers are hard to come by.) Note: the sales figures below are annualized, i.e. they are 4x the 4Q08 numbers. ]


Worldwide Lovenox sales rose 8% year-over-year to an annualized rate of €3.0B, which is $3.8B at the current exchange rate. The breakdown by geography is as follows:

US: €1.79B (60% of total), +7 YoY,
EU: €884M (30% of total), +11% YoY
RoW: €324M (11% of total), +8% YoY
===
Total: €3.00B, +8% YoY

Source:
http://en.sanofi-aventis.com/binaries/20081031_Results2008_Q3_slides_tcm28-22500.pdf


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now